Brief: Cerenis Therapeutics Holding Appoints Richard Pasternak As CEO
Dec 19 (Reuters) - CERENIS THERAPEUTICS HOLDING SA
CEREN.PA :
* APPOINTS RICHARD PASTERNAK AS CEO AND CYRILLE TUPIN AS
DEPUTY
CEO
* NEW CEO RICHARD PASTERNAK REPLACES JEAN-LOUIS DASSEUX, WHO
IS
STANDING DOWN FROM HIS EXECUTIVE DUTIES BUT WILL RETAIN HIS
PLACE ON BOARD OF DIRECTORS
Source text for Eikon: ID:nNDL56wWBH
Further company coverage: CEREN.PA
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 09 20;))
Recent news on Abionyx Pharma SA
See all newsBrief: ABIONYX Pharma And OLON Enter Into Strategic Manufacturing Partnership
France's ABIONYX Pharma H1 net loss widens as financial expenses rise
Brief: ABIONYX Pharma H1 EBIT EUR -2.27 Million
Abionyx jumps as Stifel starts coverage with 'buy'
Cardiovascular drug developer ABIONYX Pharma's H1 revenue falls